By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
American College of Chest Physicians and Canadian Thoracic Society Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Overview
This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate use of cannabinoid-based medicines in the management of chronic pain and co-concurring conditions.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: April 1, 2024
Contact: practice@apta.org
Content Type: CPG
Cancer, Chronic Pain, Depression, Fibromyalgia, Headaches, Multiple Sclerosis, Osteoarthritis, Sleep Disorders
Adult (25-44), Middle Aged (45-64), Aged (65+), 80 and over (80+)
Bell AD, MacCallum C, Margolese S, et al.
You Might Also Like...
CPG
APTA Orthopedics: Hip Pain and Mobility Deficits—Hip Osteoarthritis: Revision 2025
Recommendations for examination and diagnostic classification based on body functions and structures, activity limitations, participation restrictions,